Adrian Adams, COB, CEO and President at IMPEL NEUROPHARMA INC (IMPL), bought 37,203 shares at $13.81 ($517K) on 2021-08-18, disclosed to the SEC on 2021-08-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.81 | 17,203 | $238K | 45.9% |
| 2 | $13.81 | 17,203 | $238K | 45.9% |
| 3 | $14.91 | 2,197 | $33K | 6.3% |
| 4 | $15.89 | 600 | $10K | 1.8% |
| Total | $13.91 avg | 37,203 | $517K | 100% |
| Filing → |
| ARLZ | BUY | 2017-03-17 | $1.2M | — | Filing → |
| POZN | BUY | 2015-11-12 | $6.6M | — | Filing → |
| AUXL | SELL | 2014-12-08 | $1.4M | — | Filing → |